NCT00564174 - Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2000

Study Completion Date

September 30, 2005

Conditions

Recurrent Pregnancy LossAntiphospholipid Antibody Syndrome

Interventions

DRUG

Low molecular weight heparin and low dose aspirin

Fragmin 5000 IU/day by subcutaneous injection started at time of randomization and continued until 35 weeks gestation or delivery and low dose aspirin 81 mg/day started pre-conception and continued until 35 weeks gestation or delivery

DRUG

Low dose aspirin

81 mg enteric coated started pre-pregnancy and discontinued at 35 weeks or delivery

Trial Locations (2)

Unknown

McMaster Medical Centre, Hamilton

M5G 1X5

Mount Sinai Hosptial, Toronto